InDevR Launches 5’CapQ for Rapid Critical Quality Attribute Determination of mRNA-Based Vaccines
New Kit Lets Vaccine Manufacturers Test 5′ Capping Efficiency at [...]
InDevR Introduces Latest Solution for Influenza Vaccine Manufacturers, OmniFlu HA, to Simplify Vaccine Testing and Speed Time to Market
Validated, off-the-shelf kit for multiplexed seasonal hemagglutinin (HA) detection and [...]
InDevR Launches Expert Services to Address Vaccine Development Challenges
BOULDER, CO March 5, 2024 InDevR Inc., a global leader [...]
Webinar sponsored by bioMérieux — Next-Generation Rapid mRNA Vaccine CQA Analytics
In partnership with bioMérieux, InDevR's Erica Dawson, Ph.D., is [...]
Vaccines Research & Development – November 7-9, 2022
InDevR will be presenting an Exhibitor Talk on November [...]
